Beyond the androgen receptor: New approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond the androgen receptor: New approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting
Authors
Keywords
-
Journal
PROSTATE
Volume 74, Issue 3, Pages 314-320
Publisher
Wiley
Online
2013-11-19
DOI
10.1002/pros.22753
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer
- (2013) N. Mitsiades CANCER RESEARCH
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification
- (2013) J. R. Schoenborn et al. CLINICAL CANCER RESEARCH
- The Cancer Diaspora: Metastasis beyond the Seed and Soil Hypothesis
- (2013) K. J. Pienta et al. CLINICAL CANCER RESEARCH
- Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer
- (2013) Ai Chiin Lim et al. CURRENT DRUG TARGETS
- Lessons from in-vivo models of castration-resistant prostate cancer
- (2013) Dong Lin et al. CURRENT OPINION IN UROLOGY
- Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
- (2013) W Nathaniel Brennen et al. ENDOCRINE-RELATED CANCER
- Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer
- (2013) Pavlos Msaouel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Does the microenvironment influence the cell types of origin for prostate cancer?
- (2013) A. S. Goldstein et al. GENES & DEVELOPMENT
- Advancing Precision Medicine for Prostate Cancer Through Genomics
- (2013) Sameek Roychowdhury et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Imaging of Prostate Cancer with PET
- (2013) H. Jadvar JOURNAL OF NUCLEAR MEDICINE
- Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
- (2013) Satoshi Wada et al. Journal of Translational Medicine
- Synergistic Targeting of PI3K/AKT Pathway and Androgen Receptor Axis Significantly Delays Castration-Resistant Prostate Cancer ProgressionIn Vivo
- (2013) Christian Thomas et al. MOLECULAR CANCER THERAPEUTICS
- Drug rechallenge and treatment beyond progression—implications for drug resistance
- (2013) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
- (2013) X Yuan et al. ONCOGENE
- Targeting cell cycle and hormone receptor pathways in cancer
- (2013) C E S Comstock et al. ONCOGENE
- Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover
- (2013) C. Geng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hedgehog signaling is active in human prostate cancer stroma and regulates proliferation and differentiation of adjacent epithelium
- (2013) Sarah E. Wilkinson et al. PROSTATE
- Of mice and men-warning: Intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively
- (2013) J.P. Michiel Sedelaar et al. PROSTATE
- DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases
- (2013) M. J. Aryee et al. Science Translational Medicine
- Monitoring the Clinical Outcomes in Advanced Prostate Cancer: What Imaging Modalities and Other Markers Are Reliable?
- (2013) Michael J. Morris et al. SEMINARS IN ONCOLOGY
- Searching for Prostate Cancer Stem Cells: Markers and Methods
- (2013) Benjamin Sharpe et al. Stem Cell Reviews and Reports
- Complete Biochemical (Prostate-specific Antigen) Response to Sipuleucel-T With Enzalutamide in Castration-resistant Prostate Cancer: A Case Report With Implications for Future Research
- (2013) Julie N. Graff et al. UROLOGY
- Resistance Emerges to Second-Generation Antiandrogens in Prostate Cancer
- (2013) W. G. Nelson et al. Cancer Discovery
- Molecular Classification of Prostate Cancer Progression: Foundation for Marker-Driven Treatment of Prostate Cancer
- (2013) C. J. Logothetis et al. Cancer Discovery
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Disrupting the Networks of Cancer
- (2012) D. F. Camacho et al. CLINICAL CANCER RESEARCH
- New Strategies in Prostate Cancer: Translating Genomics into the Clinic
- (2012) H. Beltran et al. CLINICAL CANCER RESEARCH
- Combining immunological and androgen-directed approaches
- (2012) Emmanuel S. Antonarakis et al. CURRENT OPINION IN ONCOLOGY
- The reactive stroma microenvironment and prostate cancer progression
- (2012) David A Barron et al. ENDOCRINE-RELATED CANCER
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
- (2012) S. Y. Cho et al. JOURNAL OF NUCLEAR MEDICINE
- From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
- (2012) Anna V Lapuk et al. JOURNAL OF PATHOLOGY
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Traversing the genomic landscape of prostate cancer from diagnosis to death
- (2012) Haley Hieronymus et al. NATURE GENETICS
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining principles of combination drug mechanisms of action
- (2012) J. R. Pritchard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression
- (2012) J. M. Drake et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture
- (2012) Shuangling Chen et al. PROSTATE
- Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
- (2011) J. Chad Brenner et al. CANCER CELL
- Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 Therapy
- (2011) R. Waitz et al. CANCER RESEARCH
- Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer
- (2011) Gary E Gallick et al. Future Medicinal Chemistry
- Molecular States Underlying Androgen Receptor Activation: A Framework for Therapeutics Targeting Androgen Signaling in Prostate Cancer
- (2011) Peter S. Nelson JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment
- (2011) J. Lu et al. MOLECULAR CANCER THERAPEUTICS
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
- (2011) Xiaotun Zhang et al. PLoS One
- Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
- (2011) A. Kumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
- (2010) Eric Letouzé et al. GENOME BIOLOGY
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More